About Hannah Mamuszka
Hannah Mamuszka is a strategic advisor and director at Centile Bioscience.
Hannah Mamuszka reports to the SEC as a director of 1 public company: Bionano Genomics (BNGO).
Hannah Mamuszka first appears on SEC filings in 2020.
Experience
This experience comes from Hannah Mamuszka's profile and from SEC filings. For roles taken from filings, the years are when the filings name Hannah Mamuszka in the role, so the role may have started earlier or lasted longer.
Centile Bioscience Inc. Current
Strategic Advisor and director
2026 – Present · Bethesda, MD
Brain imaging analysis software for health systems and pharmaceutical teams.
CP
Carolina Health Informatics Program Current
Advisory Board Member
2021 – Present
CH
Chief Current
Founding Member
2020 – Present
AL
Alva10 Current
Founder and CEO
2016 – Present
BI
Bionano Genomics, Inc.
Director
2020 – 2026 · Public company (BNGO)
CI
Circle Cardiovascular Imaging
Board Member
2021 – 2022
ED
Exosome Diagnostics
VP of Business Development
2010 – 2015
AS
Asuragen
Strategic Business Development, Companion Diagnostics
2010
EX
Exiqon
Global Director of Pharmaceutical Alliances
2004 – 2010
ON
Oncotech
Director of Pharmaceutical Alliances
2004 – 2010
AR
ArQule
Scientist
2003 – 2004
TO
Takeda Oncology
Senior Research Associate
1999 – 2003
OR
Organogenesis
Research Associate
1998 – 1999
Key Colleagues at Startups
The people Hannah Mamuszka works with at each company, as listed on that company's latest Form D.
Centile Bioscience Inc. · Form D, Apr 16, 2026
Jakob Seidlitz
Chief Executive Officer & Co-founder, director
Richard Bethlehem
Scientific Advisor & Co-founder
LM
L. Mullins
Director
Joshua Bernstock
Chief Medical Officer & Co-founder, director